← SynDRA
CIPARGAMIN
SynDRA canonical compound SYN0022219 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Mechanism of action | antimalarial agent |
|---|
All known targets
Mechanisms of action (all sources)
- ADORA3 INHIBITOR
- KCNH2 INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- CYP2C9
- ADORA2A
- ESR2
- GHSR
- HCAR2
- HRH1
- HRH2
- HRH3
- HTR1A
- HTR2A
- HTR2B
- HTR2C
- HTR3A
- MAOA
- MC3R
- MC4R
- MLNR
- NPY1R
- NPY2R
- NR3C1
- NTSR1
- OPRD1
- OPRK1
- OPRM1
- PDE4D
- PTGS1
- PTGS2
- SLC6A2
- SLC6A3
- SLC6A4
- TACR1
- GCGR
- ESR1
- ADRA1A
- EDNRB
- ADRA2A
- ADRA2B
- ADRA2C
- ADRB1
- ADRB2
Drug classes
Cross-references
Synonyms
- Cipargamine
- Cipargamina
- KAE609
- KAE-609
- NITD-609
- NITD-609, (+)-
- NITD609
- NITD 609
- UNII-Z7Q4FWA04P
- (1'R,3'S)-5,7'-Dichloro-6'-fluoro-3'-methyl-2',3',4',9'-tetrahydrospiro[indoline-3,1'-pyrido[3,4-b]indol]-2-one
- Z7Q4FWA04P
- CHEMBL1082723
- Spiro[3H-indole-3,1'-[1H]pyrido[3,4-b]indol]-2(1H)-one, 5,7'-dichloro-6'-fluoro-2',3',4',9'-tetrahydro-3'-methyl-, (1'R,3'S)-
- Cipargamin [INN]
- GTPL9721
- SCHEMBL1306342
- DTXSID70152424
- MolPort-039-337-269
- ZINC49037032
- BDBM50318666
- AKOS027253851
- SB16518
- DB12306
- CS-7486
- NCGC00263785-01
- cipargamina
- cipargamine
- cipargaminum
- RefChem:126313
- DTXCID1074915
- C19H14Cl2FN3O
- NITD609;KAE609
- CIPARGAMIN [WHO-DD]
- orb1307962
- SCHEMBL29376912
- EX-A11065
- NCGC00263785-02
- AS-51977
- DA-56193
Look up CIPARGAMIN in the interactive SynDRA portal →